NCT ID | Drugs |
---|---|
00417807 | Imatinib mesylate |
01189643 | Iriontecan, temozolomide, bevacizumab incorporated into an existing schedule of high dose alkylator. |
00563680 | AMG-479 |
00055952 | Exatecan mesylate |
01277744 | Hyperthermic peritoneal perfusion with cisplatin. |
01099644 | Radioimmunotherapy. |
00062205 | Imatinib mesylate |
00436657 | Hyperthermic perfusion with cisplatin. |
01287104 | NK cell infusion following allogeneic stem cell transplantation. |
01125449 | Ascorbic acid (vitamin C) |
00445965 | Iodine I131 monoclonal antibody 3F8. |
00720174 | IMC-A12, doxorubicine hydrochloride. |
00003926 | Amifostine to protect form side effects of PSCT. |
00002515 | Chemotherapy in combination with bone marrow transplantation. |
00024258 | Arsenic trioxide. |
00043979 | Stem cell transplantation. |
00562380 | AMG-479. |
01154452 | GDC-0449 and RO4929097. |
00025441 | Combination chemotherapy. |
00794521 | Pazopanib. |
00474994 | Sunitinib malate |
00526149 | BI 2536 |
00002466 | Combination chemotherapy and radiation therapy. |
00030667 | Imatinib mesylate. |
00089245 | Iodine I131 monoclonal antibody 8H9. |
00093821 | Tanespimycin |
00662233 | Combination chemotherapy |
00002898 | Surgery followed by chemotherapy. |
01189253 | Doxorubicin or Trabectedin. |